Dawei Tian
6PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 08, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer.Yunkai Qie, Shiwang Huang, Chong Shen
|Jul 26, 2022
The CUSUM curve combined with comprehensive complication index for assessing short-term complications of radical cystectomy.Diansheng Zhou, Jie Gao, Yihao Liao
|Apr 07, 2020
Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.Chong Shen, Zhouliang Wu, Yujie Wang
|Jul 30, 2019
KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo.Da-Wei Tian, Zhou-Liang Wu, Li-Ming Jiang
|Dec 12, 2018
RAB38 promotes bladder cancer growth by promoting cell proliferation and motility.Da-Wei Tian, Sheng-Lai Liu, Li-Ming Jiang
|Nov 09, 2018
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer.Da-Wei Tian, Zhou-Liang Wu, Li-Ming Jiang
Pageof 1
Frequent Collaborators
2 joint publications
Hailong Hu
1 joint publications
Hailong Hu
1 joint publications
Yunkai Qie
1 joint publications
Shiwang Huang
1 joint publications
Chong Shen
1 joint publications
Zhouliang Wu
1 joint publications
La Da
1 joint publications
Kaipeng Jia
1 joint publications
Zhe Zhang
1 joint publications
Gangjian Zhao
